Skip to main content

18.08.2016 | Health Services Research

Variability in the frequency of rheumatology consultations in patients with rheumatoid arthritis in Spain

verfasst von: R. Lopez-Gonzalez, D. Seoane-Mato, S. Perez-Vicente, M. A. Martin-Martinez, F. Sanchez-Alonso, L. Silva-Fernandez, On behalf of the emAR II Study Group

Erschienen in: Rheumatology International | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

The aim of this work was to assess the variability in the use of health-care resources, based on the number of visits to rheumatology departments by rheumatoid arthritis patients, in Spain, and its association with patient, physician and center characteristics. The sample consisted of patient records of men and women (aged 16 or older), with a clinical diagnosis of RA, who met the American Rheumatism Association 1987 revised criteria and who had been treated in a rheumatology department at a Spanish hospital with at least one visit to a rheumatologist during the two years preceding the date of the study. To analyze which variables were independently associated with the number of consultations, those with a statistically significant result in the bivariate analysis, or which were clinically relevant or deemed confounders, were used in the construction of a linear regression model. The records of 1188 RA patients were studied. The linear regression model explained the 26.67 % of the variability in the number of visits. The number of csDMARDs prescribed, the administration of biological therapy, corticoid prescription, the presence of nursing consultation, mean time to first visit in the department and attended population showed a positive significant association, while the presence of telephone consultation, distance from the hospital to the patient´s residence (≥20 km) and drug monitoring by rheumatology department + primary care physician or by other specialists were negatively associated with the number of consultations. We observed a high variability in the number of visits, which remains partially unexplained even after taking into account individual, physician and center characteristics.
Literatur
1.
Zurück zum Zitat Carmona L, Villaverde V, Hernández-García C, Ballina J, Gabriel R, Laffon A, EPISER Study Group (2002) The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology (Oxford) 41(1):88–95CrossRef Carmona L, Villaverde V, Hernández-García C, Ballina J, Gabriel R, Laffon A, EPISER Study Group (2002) The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology (Oxford) 41(1):88–95CrossRef
2.
Zurück zum Zitat Puolakka K, Kautiainen H, Pekurinen M, Möttönen T, Hannonen P, Korpela M, FIN-RACo Trial Group et al (2006) Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients’ sickness absence and gross income: experience from the FIN-RACo trial. Ann Rheum Dis 65(7):899–904CrossRefPubMed Puolakka K, Kautiainen H, Pekurinen M, Möttönen T, Hannonen P, Korpela M, FIN-RACo Trial Group et al (2006) Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients’ sickness absence and gross income: experience from the FIN-RACo trial. Ann Rheum Dis 65(7):899–904CrossRefPubMed
3.
Zurück zum Zitat Burton WN, Chen CY, Schultz AB, Conti DJ, Pransky G, Edington DW (2006) Worker productivity loss associated with arthritis. Dis Manag 9(3):131–143CrossRefPubMed Burton WN, Chen CY, Schultz AB, Conti DJ, Pransky G, Edington DW (2006) Worker productivity loss associated with arthritis. Dis Manag 9(3):131–143CrossRefPubMed
4.
Zurück zum Zitat Yelin E, Trupin L, Wong B, Rush S (2002) The impact of functional status and change in functional status on mortality over 18 years among persons with rheumatoid arthritis. J Rheumatol 29(9):1851–1857PubMed Yelin E, Trupin L, Wong B, Rush S (2002) The impact of functional status and change in functional status on mortality over 18 years among persons with rheumatoid arthritis. J Rheumatol 29(9):1851–1857PubMed
5.
Zurück zum Zitat Gaujoux-Viala C, Nam J, Ramiro S, Landewé R, Buch MH, Smolen JS, Gossec L (2014) Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 73(3):510–515CrossRefPubMedPubMedCentral Gaujoux-Viala C, Nam J, Ramiro S, Landewé R, Buch MH, Smolen JS, Gossec L (2014) Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 73(3):510–515CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Jacobs JW (2012) Optimal use of non-biologic therapy in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 51(Suppl 4):iv3–iv8 Jacobs JW (2012) Optimal use of non-biologic therapy in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 51(Suppl 4):iv3–iv8
7.
Zurück zum Zitat Ruiz-Montesinos MD, Hernández-Cruz B, Ariza-Ariza R, Carmona L, Ballina J, Navarro-Sarabia F, Grupo de Estudio de Costes, Calidad de Vida en Artritis Reumatoide de la Sociedad Española de Reumatología (2005) Resource utilization in a cohort of rheumatoid arthritis patients attended in rheumatology units in Spain. Reumatol Clin 1(3):142–149CrossRefPubMed Ruiz-Montesinos MD, Hernández-Cruz B, Ariza-Ariza R, Carmona L, Ballina J, Navarro-Sarabia F, Grupo de Estudio de Costes, Calidad de Vida en Artritis Reumatoide de la Sociedad Española de Reumatología (2005) Resource utilization in a cohort of rheumatoid arthritis patients attended in rheumatology units in Spain. Reumatol Clin 1(3):142–149CrossRefPubMed
8.
Zurück zum Zitat van den Hout WB, Bremander A, Vliet Vlieland TP (2011) Recommendations for economic evaluations of non-pharmacological arthritis care: results from the CARE VI meeting 2010. Musculoskelet Care 9(2):120–123CrossRef van den Hout WB, Bremander A, Vliet Vlieland TP (2011) Recommendations for economic evaluations of non-pharmacological arthritis care: results from the CARE VI meeting 2010. Musculoskelet Care 9(2):120–123CrossRef
9.
Zurück zum Zitat Ruiz-Montesinos MD, Hernández-Cruz B, Ariza-Ariza R, Carmona L, Ballina J, Navarro-Sarabia F, Grupo de estudio de Costes y Calidad de Vida en Artritis Reumatoide de la Sociedad Española de Reumatología (2005) Cost analysis in a cohort of rheumatoid arthritis patients managed in rheumatology units in Spain. Reumatol Clin 1(4):193–199CrossRefPubMed Ruiz-Montesinos MD, Hernández-Cruz B, Ariza-Ariza R, Carmona L, Ballina J, Navarro-Sarabia F, Grupo de estudio de Costes y Calidad de Vida en Artritis Reumatoide de la Sociedad Española de Reumatología (2005) Cost analysis in a cohort of rheumatoid arthritis patients managed in rheumatology units in Spain. Reumatol Clin 1(4):193–199CrossRefPubMed
10.
Zurück zum Zitat Schoels M, Wong J, Scott DL, Zink A, Richards P, Landewé R et al (2010) Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 69(6):995–1003CrossRefPubMed Schoels M, Wong J, Scott DL, Zink A, Richards P, Landewé R et al (2010) Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 69(6):995–1003CrossRefPubMed
11.
Zurück zum Zitat Corallo AN, Croxford R, Goodman DC, Bryan EL, Srivastava D, Stukel TA (2014) A systematic review of medical practice variation in OECD countries. Health Policy 114(1):5–14CrossRefPubMed Corallo AN, Croxford R, Goodman DC, Bryan EL, Srivastava D, Stukel TA (2014) A systematic review of medical practice variation in OECD countries. Health Policy 114(1):5–14CrossRefPubMed
12.
Zurück zum Zitat González-Alvaro I, Hernández-García C, Villaverde García E, Vargas E, Ortiz AM (2002) Variations in the drug treatment of rheumatoid arthritis in Spain. Med Clin 118(20):771–776CrossRef González-Alvaro I, Hernández-García C, Villaverde García E, Vargas E, Ortiz AM (2002) Variations in the drug treatment of rheumatoid arthritis in Spain. Med Clin 118(20):771–776CrossRef
13.
Zurück zum Zitat Lopez-Gonzalez R, Hernandez-Garcia C, Abasolo L, Morado I, Lajas C, Vadillo C, Pato E, Fernandez-Gutierrez B, Jover JA, Loza E, emAR Study Group (2008) Differences between rheumatology attending physicians and training residents in the management of rheumatoid arthritis in Spain. Scand J Rheumatol 37(6):419–426CrossRefPubMed Lopez-Gonzalez R, Hernandez-Garcia C, Abasolo L, Morado I, Lajas C, Vadillo C, Pato E, Fernandez-Gutierrez B, Jover JA, Loza E, emAR Study Group (2008) Differences between rheumatology attending physicians and training residents in the management of rheumatoid arthritis in Spain. Scand J Rheumatol 37(6):419–426CrossRefPubMed
14.
Zurück zum Zitat Silva-Fernández L, Pérez-Vicente S, Martín-Martínez MA, López-González R, on behalf of the emAR II Study Group (2015) Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain. Semin Arthritis Rheum 44(6):633–640CrossRefPubMed Silva-Fernández L, Pérez-Vicente S, Martín-Martínez MA, López-González R, on behalf of the emAR II Study Group (2015) Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain. Semin Arthritis Rheum 44(6):633–640CrossRefPubMed
15.
Zurück zum Zitat Rosales-Alexander JL, Balsalobre Aznar J, Pérez-Vicente S, Magro-Checa C (2015) Drug survival of anti-tumour necrosis factor α therapy in spondyloarthropathies: results from the Spanish emAR II Study. Rheumatology (Oxford) 54(8):1459–1463CrossRef Rosales-Alexander JL, Balsalobre Aznar J, Pérez-Vicente S, Magro-Checa C (2015) Drug survival of anti-tumour necrosis factor α therapy in spondyloarthropathies: results from the Spanish emAR II Study. Rheumatology (Oxford) 54(8):1459–1463CrossRef
16.
Zurück zum Zitat Loza E, Abasolo L, Clemente D, Lopez-Gonzalez R, Rodriguez L, Vadillo C et al (2007) Variability in the use of orthopedic surgery in patients with rheumatoid arthritis in Spain. J Rheumatol 34:1485–1490PubMed Loza E, Abasolo L, Clemente D, Lopez-Gonzalez R, Rodriguez L, Vadillo C et al (2007) Variability in the use of orthopedic surgery in patients with rheumatoid arthritis in Spain. J Rheumatol 34:1485–1490PubMed
17.
Zurück zum Zitat Maese J, García De Yébenes MJ, Carmona L, Hernández-García C, el Grupo de Estudio emAR II (2012) Management of rheumatoid arthritis in Spain emAR II. Clinical characteristics of the patients. Reumatol Clin 8(5):236–242CrossRefPubMed Maese J, García De Yébenes MJ, Carmona L, Hernández-García C, el Grupo de Estudio emAR II (2012) Management of rheumatoid arthritis in Spain emAR II. Clinical characteristics of the patients. Reumatol Clin 8(5):236–242CrossRefPubMed
18.
Zurück zum Zitat Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–48CrossRefPubMed Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–48CrossRefPubMed
19.
Zurück zum Zitat Pincus T, Swearingen C, Wolfe F (1999) Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 42(10):2220–2230CrossRefPubMed Pincus T, Swearingen C, Wolfe F (1999) Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 42(10):2220–2230CrossRefPubMed
20.
Zurück zum Zitat Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35(5):498–502CrossRefPubMed Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35(5):498–502CrossRefPubMed
21.
Zurück zum Zitat Standfield L, Norris S, Harvey C, Elliot L, Riordan J, Hall S, Day R, Nash P, Thirunavukkarasu K, Robertson J, Palmer T (2010) Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in Australian patients: a cross-sectional, multicenter study. Clin Ther 32(7):1329–1342CrossRefPubMed Standfield L, Norris S, Harvey C, Elliot L, Riordan J, Hall S, Day R, Nash P, Thirunavukkarasu K, Robertson J, Palmer T (2010) Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in Australian patients: a cross-sectional, multicenter study. Clin Ther 32(7):1329–1342CrossRefPubMed
22.
Zurück zum Zitat Zink A, Thiele K, Huscher D, Listing J, Sieper J, Krause A et al (2006) Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 33:86–90PubMed Zink A, Thiele K, Huscher D, Listing J, Sieper J, Krause A et al (2006) Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 33:86–90PubMed
23.
Zurück zum Zitat Zink A, Listing J, Ziemer S, Zeidler H, German Collaborative Arthritis C (2001) Practice variation in the treatment of rheumatoid arthritis among German rheumatologists. J Rheumatol 28:2201–2208PubMed Zink A, Listing J, Ziemer S, Zeidler H, German Collaborative Arthritis C (2001) Practice variation in the treatment of rheumatoid arthritis among German rheumatologists. J Rheumatol 28:2201–2208PubMed
24.
Zurück zum Zitat Ndosi M, Lewis M, Hale C, Quinn H, Ryan S, Emery P, Bird H, Hill J (2014) The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial. Ann Rheum Dis 73(11):1975–1982CrossRefPubMed Ndosi M, Lewis M, Hale C, Quinn H, Ryan S, Emery P, Bird H, Hill J (2014) The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial. Ann Rheum Dis 73(11):1975–1982CrossRefPubMed
25.
Zurück zum Zitat Koksvik HS, Hagen KB, Rødevand E, Mowinckel P, Kvien TK, Zangi HA (2013) Patient satisfaction with nursing consultations in a rheumatology outpatient clinic: a 21-month randomised controlled trial in patients with inflammatory arthritis. Ann Rheum Dis 72(6):836–843CrossRefPubMed Koksvik HS, Hagen KB, Rødevand E, Mowinckel P, Kvien TK, Zangi HA (2013) Patient satisfaction with nursing consultations in a rheumatology outpatient clinic: a 21-month randomised controlled trial in patients with inflammatory arthritis. Ann Rheum Dis 72(6):836–843CrossRefPubMed
26.
Zurück zum Zitat Primdahl J, Sørensen J, Horn HC, Petersen R, Hørslev-Petersen K (2014) Shared care or nursing consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis outpatients with low disease activity–patient outcomes from a 2-year, randomised controlled trial. Ann Rheum Dis 73(2):357–364CrossRefPubMed Primdahl J, Sørensen J, Horn HC, Petersen R, Hørslev-Petersen K (2014) Shared care or nursing consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis outpatients with low disease activity–patient outcomes from a 2-year, randomised controlled trial. Ann Rheum Dis 73(2):357–364CrossRefPubMed
27.
Zurück zum Zitat van Nies JA, Tsonaka R, Gaujoux-Viala C, Fautrel B, van der Helm-van Mil AH (2015) Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden Early Arthritis Clinic and ESPOIR cohorts. Ann Rheum Dis 74(5):806–812CrossRefPubMed van Nies JA, Tsonaka R, Gaujoux-Viala C, Fautrel B, van der Helm-van Mil AH (2015) Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden Early Arthritis Clinic and ESPOIR cohorts. Ann Rheum Dis 74(5):806–812CrossRefPubMed
28.
Zurück zum Zitat van Nies JA, Krabben A, Schoones JW, Huizinga TW, Kloppenburg M, van der Helm-van Mil AH (2014) What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann Rheum Dis 73(5):861–870CrossRefPubMed van Nies JA, Krabben A, Schoones JW, Huizinga TW, Kloppenburg M, van der Helm-van Mil AH (2014) What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann Rheum Dis 73(5):861–870CrossRefPubMed
29.
Zurück zum Zitat Birnbaum HG, Pike C, Banerjee R, Waldman T, Cifaldi M (2012) Changes in utilization and costs for patients with rheumatoid arthritis, 1997–2006. Pharmacoeconomics 30(4):323–336CrossRefPubMed Birnbaum HG, Pike C, Banerjee R, Waldman T, Cifaldi M (2012) Changes in utilization and costs for patients with rheumatoid arthritis, 1997–2006. Pharmacoeconomics 30(4):323–336CrossRefPubMed
30.
Zurück zum Zitat Anis AH, Guh DP, Lacaille D, Marra CA, Rashidi AA, Li X, Esdaile JM (2005) When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions. CMAJ 173(11):1335–1340CrossRefPubMedPubMedCentral Anis AH, Guh DP, Lacaille D, Marra CA, Rashidi AA, Li X, Esdaile JM (2005) When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions. CMAJ 173(11):1335–1340CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Põlluste K, Kallikorm R, Meiesaar K, Lember M (2012) Use of general practice and rheumatology outpatient services in rheumatoid arthritis. Fam Pract 29(4):433–440CrossRefPubMed Põlluste K, Kallikorm R, Meiesaar K, Lember M (2012) Use of general practice and rheumatology outpatient services in rheumatoid arthritis. Fam Pract 29(4):433–440CrossRefPubMed
32.
Zurück zum Zitat Stockl KM, Shin JS, Lew HC, Zakharyan A, Harada AS, Solow BK, Curtis BS (2010) Outcomes of a rheumatoid arthritis disease therapy management program focusing on medication adherence. J Manag Care Pharm 16(8):593–604PubMed Stockl KM, Shin JS, Lew HC, Zakharyan A, Harada AS, Solow BK, Curtis BS (2010) Outcomes of a rheumatoid arthritis disease therapy management program focusing on medication adherence. J Manag Care Pharm 16(8):593–604PubMed
33.
Zurück zum Zitat Pincus T, Yazici Y, Sokka T (2007) Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations. Best Pract Res Clin Rheumatol 21:601–628CrossRefPubMed Pincus T, Yazici Y, Sokka T (2007) Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations. Best Pract Res Clin Rheumatol 21:601–628CrossRefPubMed
Metadaten
Titel
Variability in the frequency of rheumatology consultations in patients with rheumatoid arthritis in Spain
verfasst von
R. Lopez-Gonzalez
D. Seoane-Mato
S. Perez-Vicente
M. A. Martin-Martinez
F. Sanchez-Alonso
L. Silva-Fernandez
On behalf of the emAR II Study Group
Publikationsdatum
18.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 11/2016
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3547-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.